期刊文献+

一种新型NGF缓释系统的制备 被引量:4

A New Type Release-Controll System of NGF
在线阅读 下载PDF
导出
摘要 目的制备一种新型-βNGF缓释系统,通过Sandwich ELISA法建立-βNGF标准释放曲线及无细胞存在下体外释放曲线,检测缓释系统能否延缓释放-βNGF。方法利用纤维蛋白作为释放系统基质,加入肝素、肝素结合肽、-βNGF及含Ca^2+的凝血酶制成-βNGF缓释系统,加入24孔组织培养板内,37℃,95%相对湿度,5%CO2培养箱中培育5~10 min,然后每天加500μL/孔TBS液轻轻冲洗,小心吸取冲洗液收集于EP管内,共6d,最后加100μL/孔含纤溶酶的TBS液将基质完全溶解,收集基质溶解液于EP管中,用Sandwich ELISA法测定每天冲洗液含有的-βNGF的量和最后基质溶解液中剩余-βNGF的量,建立-βNGF浓度-时间释放曲线。实验分为2组,实验组:fibrin+heparin+peptide+100 ng/mL-βNGF;对照组:fibrin+100 ng/mL-βNGF。结果第1天,对照组有98.23%的NGF释放出来,而NGF缓释系统组只释放21.37%,明显少于对照组(P〈0.01);对照组最后的基质溶解液中无NGF剩余,而实验组仍有48.92%的NGF剩余(P〈0.01)。结论在体外无细胞存在情况下,实验组能明显延缓NGF的释放,延缓时间在6 d以上。 Objective To establish a new β-NGF delivery system for controlled release and the release profile of β-NGF using Sandwich ELISA. Methods The fibrin was selected as matrix and the NGF controlled release system concluding heparin-binding peptides and heparin and β-NGF. The experiment was divided into two groups: Experiment group: fibrin + heparin + peptide + 100 ng/mL β-NGF;Control group:fibrin+100 ng/mL β-NGF Fibrin matrices were washed every day with 500 μL TBS per wash. The washes from the matrices were collected and stored in -20℃. After 6 days,the matrices were degraded with plasmin. The amount of β-NGF presenting in the washes and remaining in the matrices was quantified using Sandwich ELISA. The release profile of β-NGF was established. Results Without the heparin-binding peptides and heparin,almost all of the β-NGF(98.23%)was released from the matrix within the first day. However,only 21.37% of the β-NGF initially presented in experiment group was released within the first day and 48.92% of the β-NGF still remained in the matrix after 6 days. Conclusion These results demonstrated that the release of β-NGF from β-NGF controlled system is prolonged obviously in vitro.
出处 《实用临床医学(江西)》 CAS 2008年第2期3-6,共4页 Practical Clinical Medicine
关键词 神经生长因子 缓释 纤维蛋白 肝素结合肽 nerve growth factor controlled release fibrin heparin-binding peptide
  • 相关文献

参考文献8

  • 1Tsai C C, Lu M C,Chen Y S,et al. Locally Administered .Nerve Growth Factor Suppresses Ginsenoside Rbl-enhanced Peripheral nerve Regeneration[J]. Am J Chin Med, 2003,31 (5) : 665- 673.
  • 2Xu X, Yee W C, Hwang P Y,et al. Peripheral Nerve Regenera- tion with Sustainted Release of Poly(phosphoester)Microen- capsulated nerve Growth Factor with Nerve Guide Conduits [J]. Biomaterials, 2003,24 ( 13 ) : 2405-2412.
  • 3Sakiyama-Elbert S E,Schense J C, Hubbell J A. Incorporation of Heparin-hinding Peptides into Fibrin Gels Enhances Neurite extension., an Example of Designer Matrices in Tissue Engineering[J]. Faseb J, 1999,13: 2214-2224.
  • 4Xu X, Yu H,Gao S, et al. Polyphosphoester Microspheres for Sustained Release of Biologically Active nerve Growth Factor []J. Biomaterials, 2002,23 (17) : 3765-3772.
  • 5Sakiyama-Elbert S E, Hubbell J A. Development of Fibrin Derivatives for Controlled Release of Heparin-binding Growth Factors[J]. J Control Release, 2000,65 : 389-402.
  • 6Sara J T,John W M. Sakiyama-Elbert S E. Controlled Release of Neurotrophin-3 from Fibrin Gels for Spinal Cord Injury[J]. J Control Release, 2004,98 : 281-294.
  • 7Sakiyama S, Schense J, Hubbell J. Heparin-binding Peptides Enhance Neurite Extension in three-dimensional Fibrin Gels [J]. FASEB J, 1999,13( 15)in press.
  • 8Sakiyama-Elbert S E, Hubbell J. A. Controlled Release of Nerve Growth Factor from a Heparin-containing Fibrin-based Cell Ingrowth Matrix[J]. J Control Release,2000,69 : 149-158.

同被引文献111

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部